These findings did not reach statistical significance but were consistent with the literature. 4 , 17 BCL2 overexpression does not carry any prognostic significance on its own, especially in the rituximab era. 5 CD5-positive cases accounted for 9.1% of cases in our study, a similar proportion to the 5% to 10% reported in the literature, 35 with 10 of the 11 cases occurring in men.
← all excerpts
Diffuse Large B-Cell Lymphoma in Kenya: MYC, BCL2, and the Cell of Origin.
1
—
—